Octave director granted 7,441 restricted stock units
Octave Specialty Group director Joan M. LammTennant received a grant of 7,441 restricted stock units (RSUs), each representing a contingent right to one share of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Octave Specialty Group director Joan M. LammTennant received a grant of 7,441 restricted stock units (RSUs), each representing a contingent right to one share of common stock.
The RSUs were granted on April 1, 2026 and are scheduled to vest on April 1, 2027. Vested RSUs will convert into common shares on the earlier of the vesting date or when she ceases to serve on the Board, unless she elects to defer settlement. Following this award, she directly holds 16,091 RSUs tied to Octave Specialty Group common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 7,441 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Octave Specialty Group, Inc. (the "Company").
- F2. RSU's granted on April 1, 2026 shall vest one year later on April 1, 2027. RSUs that have become vested shall settle and convert into shares of common stock upon the earlier of the vesting date or the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company, unless otherwise deferred upon the election of the Reporting person.
Key Figures
Key Terms
Restricted Stock Units financial
contingent right financial
vest financial
Board of Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did OSG director Joan M. LammTennant report on this Form 4?
How many restricted stock units were granted to the OSG director and what do they represent?
When do Joan M. LammTennant’s new OSG restricted stock units vest and settle?
What are Joan M. LammTennant’s total OSG restricted stock unit holdings after this grant?
Is this OSG Form 4 transaction a market purchase or sale of common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.